ArticleThe Journal of biological chemistry2020

Inhibition of the erythropoietin-producing receptor EPHB4 antagonizes androgen receptor overexpression and reduces enzalutamide resistance.

Chaohao Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.